Related Experiment Videos
High-level gentamicin-resistant and vancomycin-resistant Enterococcus faecium isolated from a wound in a dog
Y Abbott1, B M Kirby, M Karczmarczyk
1Unit of Veterinary Surgery, University College Dublin, Belfield, Dublin 4, Ireland.
The Journal of Small Animal Practice
|November 29, 2008
Summary
A dog in Europe was diagnosed with a high-level gentamicin-resistant and vancomycin-resistant Enterococcus faecium infection. This case highlights the emerging threat of multidrug-resistant bacteria in companion animals.
Area of Science:
- Veterinary Medicine
- Infectious Diseases
- Microbiology
Background:
- Multidrug-resistant (MDR) Enterococcus faecium poses significant challenges in human healthcare settings.
- The emergence of MDR pathogens in companion animals is an increasing concern.
- Enterococcus faecium is a common bacterium found in the gastrointestinal tract of animals and humans.
Observation:
- This report details the first documented clinical case in Europe of a dog infected with high-level gentamicin-resistant and vancomycin-resistant Enterococcus faecium (GRev-VREfm).
- The dog presented with clinical signs consistent with a bacterial infection.
- Diagnostic testing confirmed the presence of the specific MDR Enterococcus faecium strain.
Findings:
- The isolated Enterococcus faecium strain exhibited resistance to both high-level gentamicin and vancomycin.
- This specific GRev-VREfm strain was identified as the causative agent of the infection in the canine patient.
- The resistance profile indicates a significant public health concern due to the limited treatment options.
Implications:
- This case serves as a critical alert to the veterinary profession regarding the presence of GRev-VREfm in companion animals.
- There is a potential for similar MDR Enterococcus faecium strains to impact veterinary medicine, mirroring issues in human healthcare.
- Further surveillance and infection control measures are warranted in veterinary settings to mitigate the spread of antimicrobial resistance.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...